Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
100%
Syrian Hamster
100%
Antibody Response
83%
Viral Disease
65%
Immunoglobulin G Antibody
55%
Virus Infectivity
55%
Cytomegalovirus
50%
Human Immunodeficiency Virus 1
50%
Rhesus Monkey
50%
Mouse
50%
Platelet
50%
Measles
50%
Salivary Gland
50%
Human Immunodeficiency Virus Infection
50%
Hamster Model
50%
Sex Difference
50%
Immunodeficiency
50%
Mental Stress
50%
Macaca nemestrina
50%
Rebound
50%
Innate Immune System
40%
Simian Immunodeficiency Virus
40%
Lymphoid Tissue
33%
Measles Virus
33%
Immunoglobulin G
30%
Human Immunodeficiency Virus
30%
Bioluminescence
30%
Monocyte
20%
Platelet Count
20%
Monospecific Antibody
20%
Neutralization
20%
Thrombocyte Activation
20%
Peripheral Blood Mononuclear Cell
16%
Body Weight
16%
Lymphocytopenia
16%
Virology
16%
Immunology
16%
Alveolar Macrophage
16%
SARS Coronavirus
16%
Lung Weight
16%
Morphology
16%
Blood Plasma
16%
Neutralizing Antibody
15%
Viral Replication
15%
Viral Load
14%
Immune Response
14%
Virus Antibody
11%
Viremia
10%
CD14
10%
Keyphrases
Virus
58%
Rhesus Macaque
50%
Syrian Hamster Model
50%
Measles
50%
Cytomegalovirus Replication
50%
Human Immunodeficiency Virus Type 1 (HIV-1)
50%
Animal Research
50%
Salivary Gland
50%
Pandemic Response
50%
Immunoglobulin G Antibodies
50%
COVID-19
50%
Exposure Therapy
50%
Remdesivir
50%
Syrian Hamster
50%
Pre-exposure Prophylaxis (PrEP)
50%
Platelets
50%
Latent Reservoir
50%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
50%
Pregenomic RNA (pgRNA)
35%
Inoculation
30%
Infectious Virus
28%
Respiratory Tract
26%
Clinical Disease
25%
Viral Outgrowth Assay
22%
Lung
20%
Murine CMV
18%
Virus RNA
18%
Lymphoid Tissue
16%
Late Treatment
16%
Antibody Response
16%
Euthanized
16%
Immunoglobulin G
13%
Antiretroviral Therapy
12%
COVID-19 Pandemic
12%
Current Response
12%
Cytomegalovirus Infection
12%
Platelet Depletion
12%
Therapy Development
12%
1918 Spanish Flu
12%
Scientific Community
12%
Zika Outbreak
12%
Major Infectious Diseases
12%
Innate Immune Parameters
12%
SARS-CoV-2 Vaccine
12%
Disease Therapy
12%
Epidemic Response
12%
Key Discovery
12%
Spanish Flu Pandemic
12%
Ebola Outbreak
12%
Endothelium
12%
Medicine and Dentistry
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infection
75%
Salivary Gland
50%
Sex Difference
50%
Antibody Response
50%
Platelet
50%
Cytomegalovirus
50%
Virus Infectivity
38%
Virus RNA
33%
Disease
27%
Body Weight
16%
Histopathology
16%
Clinical Pathology
16%
Hyperplasia
16%
SARS Coronavirus
16%
Morphology
16%
Alveolar Macrophage
16%
Clinical Immunology
16%
Necrosis
16%
Image Analysis
16%
Diethylstilbestrol
11%
Virus Antibody
11%
Pulmonary Pathology
11%
Cytomegalovirus Infection
9%
Virus Infection
9%
Trachea
5%
Inflammatory Cytokine
5%
Virus Replication
5%
Receptor Binding
5%
Immunoglobulin G Antibody
5%
Lung Injury
5%
Cytokine
5%
Immunoglobulin M
5%
Tumor Necrosis Factor
5%
Immunoglobulin A
5%
Protein S
5%
Turbinate
5%
Neutralizing Antibody
5%
Computer Assisted Tomography
5%
Interferon
5%
